- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00009802 | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | University of PittsburghOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00009828 |
| Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors |
| withdrawn |
| Phase 1 |
| 0 |
| University of PittsburghOTHER |
| 0 |
| Dec 19, 2013 |
| clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00017524 | AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors | completed | Phase 1 | 22 | University of Alabama at BirminghamOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00019708 | Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00070239 | Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies | terminated | Phase 1 | 100 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00243100 | Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00390052 | 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00103220 | SJG-136 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00369200 | AFP464 in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00002482 | Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00293345 | 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00006088 | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00023816 | Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00060151 | GW786034 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01159301 | Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00324597 | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00387504 | Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 21 | California Cancer ConsortiumNETWORK | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00002939 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | completed | Phase 1 | 21 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00020644 | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer | unknown | Phase 1 | — | Advocate Lutheran General HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | unknown | Phase 1 | 35 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00003108 | Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Lombardi Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004213 | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | completed | Phase 1 | 17 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00004090 | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00045318 | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00072228 | Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | withdrawn | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00012194 | 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00072436 | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00331955 | Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00036777 | UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00003198 | Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 19, 2013source: clinicaltrials